CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

CADTH Weekly COVID-19 Update

Last updated: June 15, 2020
Product Line: New at CADTH
Result type: Report

CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.

Our COVID-19 evidence portal contains the latest COVID-19 information from CADTH and other respected organizations. Content is updated daily to reflect the rapidly changing and growing state of the international scientific evidence related to this disease.

The following is a summary of the most recent information posted to our COVID-19 portal.

Events

WEBINAR: Surviving the COVID-19 Infodemic – Can You Trust Dr. Google? (June 23, 2020)

  • Register to attend this free webinar moderated by CADTH’s Chief Scientist and Vice-President of Evidence Standards, Nicole Mittmann, to learn about the work underway to curtail the spread of misinformation. You’ll also get practical tips and tools to help find reliable sources of health information and evaluate their quality.
  • Speakers include:
    • Timothy Caulfield, Canada Research Chair in Health Law and Policy, Professor in the Faculty of Law and the School of Public Health, and Research Director of the Health Law Institute at the University of Alberta
    • Barbara Greenwood-Dufour, Knowledge Mobilization Officer, CADTH.

PREVIOUSLY RECORDED WEBINAR: Psychological Trauma Due to the COVID-19 Pandemic: Can Technology Help in a Time of Acute Crisis? (June 11, 2020)

Reports

Venous Thromboembolism Prophylaxis in Patients Hospitalized With COVID-19

  • Patients hospitalized with COVID-19, particularly those in intensive care units, are at an increased risk for venous thromboembolism (VTE).
  • CADTH’s Horizon Scan identified seventeen studies reporting on the frequency of VTE in patients hospitalized with COVID-19.
  • The Horizon Scan also summarized Canadian and international guidance regarding the dose and duration of pharmacologic thromboprophylaxis for VTE prevention in patients with COVID-19 and listed clinical trials that are currently underway.

Ongoing Trials for Drugs in the Prevention and Treatment of COVID-19

  • This report provides information on randomized controlled trials of drugs being investigated for the prevention or treatment of COVID-19.
  • As of May 28, 2020, a total of 92 ongoing drug trials related to COVID-19 are registered on the ClinicalTrials.gov website.
  • Most of the trials are being conducted in adult patients who are hospitalized and six trials have Canadian study sites.

CADTH Literature Searching Tools

To help conduct your COVID-19–related literature searches, access our COVID-19 Search Strings and our COVID-19 Grey Literature Resources.

Additional Resources

CADTH is pleased to showcase additional COVID-19 resources from our partner organizations, as well as from the Canadian federal, provincial, and territorial governments’ health jurisdictions:

Can't Find What You Need? Let Us Know.

Canadian ministries and departments of health, publicly funded organizations responsible for health service delivery, and clinical society stakeholders are encouraged to submit a request or contact their CADTH Liaison Officer. We’re here to help.

The CADTH Weekly COVID-19 Update is intended to keep you informed about the latest information posted on the CADTH COVID-19 portal. You’re receiving this update because you’ve subscribed to our CADTH e-alert system.